CYBB and Insulin resistance: NOX2 activation may contribute to glucose intolerance during early stages of diet-induced obesity, whereas the upregulation of NOX2 following the onset of insulin resistance may promote clearance of dead adipocytes and reduce ectopic lipid deposition.